Document Detail

Taenia crassiceps: Host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.
MedLine Citation:
PMID:  22127328     Owner:  NLM     Status:  Publisher    
Human cysticercosis by Taenia crassiceps is rare although it is considered of zoonotic risk, especially to immunocompromised individuals. Albendazole and praziquantel are widely used and effective in its treatment. Their active forms inhibit the glucose uptake by the parasite and induce muscle contractions that alter its glycogen levels interfering in the energetic metabolism of the parasite and leading to its death. The aim of this study was to evaluate alterations in glycolysis, the tricarboxylic acid cycle and glucose concentrations caused by low dosage treatments of the hosts with albendazole and praziquantel. Therefore, T. crassiceps intraperitoneally infected mice were treated by gavage feeding with 5.75 or 11.5mg/kg of albendazole and 3.83 or 7.67mg/kg of praziquantel. The treated mice were euthanized after 24h and the cysticerci collected were morphologically classified into initial, larval or final phases. Concentrations of the organic acid produced and glucose were evaluated to detect alterations into the glycolysis and the tricarboxylic acid cycle pathways through chromatography and spectrophotometry. The low dosage treatment caused a partial blockage of the glucose uptake by the cysticerci in spite of the non significant difference between its concentrations. An activation of the tricarboxylic acid cycle was noted in the cysticerci that received the treatment due to an increase in the production of citrate, malate and α-ketoglutarate and the consumption of oxaloacetate, succinate and fumarate. The detection of α-ketoglutarate indicates that the cysticerci which were exposed to the drugs after host treatment present different metabolic pathways than the ones previously described after in vitro treatment.
Carolina Miguel Fraga; Tatiane Luiza Costa; José Clecildo Barreto Bezerra; Ruy de Souza Lino; Marina Clare Vinaud
Related Documents :
12587978 - Effects of epidermal growth factor and linoleic acid on lipid contents in human intesti...
11597788 - Fatty acid composition of lymphocyte membrane phospholipids in children with acute leuk...
18826588 - Conjugated linoleic acid content of human plasma.
20417878 - Conjugated linoleic acid alters caveolae phospholipid fatty acid composition and decrea...
1499028 - The polysaccharides of agricultural lupin seeds.
12771358 - Application of the concepts of risk assessment to the study of amino acid supplements.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-22
Journal Detail:
Title:  Experimental parasitology     Volume:  -     ISSN:  1090-2449     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370713     Medline TA:  Exp Parasitol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Inc.
Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Rua 235, s/n, Setor Universitário, Goiânia, Goiás, Brasil CEP: 74650-050, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Toxicology and Carcinogenesis Studies of alpha,beta-Thujone (CAS No. 76231-76-0) in F344/N Rats and ...
Next Document:  Stress induced half-metallicity in surface defected germanium nanowires.